| Literature DB >> 34221393 |
Marco Allinovi1, Wesley Hayes2,3.
Abstract
Entities:
Year: 2021 PMID: 34221393 PMCID: PMC8243277 DOI: 10.1093/ckj/sfab041
Source DB: PubMed Journal: Clin Kidney J ISSN: 2048-8505
Patient characteristics: clinical and epidemiological data
| All patients on chronic haemodialysis ( | |
|---|---|
| Age at onset of study, years | 13.6 (4.1–16.4) |
| Gender distribution (M:F) | 9:5 |
| Duration of renal replacement therapy, months | 8.5 (4.0–37.0) |
| Diagnosis of nephropathy | ANCA vasculitis (2), congenital FSGS, genetic FSGS, nephronophthisis (2), atypical haemolytic uraemic syndrome (2), SLE (2), immunoglobulin A nephropathy, bilateral hypodysplasia (3) and bilateral Wilms tumour |
| Percentage increase of interdialytic weight gain/dry weight | 3.3 (0–8.6) |
| Oligoanuria, | 3/15 |
| Left ventricular hypertrophy, | 9/15 |
| NT-proBNP, mean | 2906 (159–55 520) |
| Physical signs or symptoms of overt fluid overload, |
12/42 (29) assessments 6/15 (40) patients |
Data are presented as median and range. ANCA, anti-neutrophil cytoplasmic autoantibody; FSGS, focal segmental glomerulosclerosis; F, female; M, male; NT-proBNP, N-terminal pro-brain natriuretic peptide; SLE, systemic lupus erythematosus.
FIGURE 1: Comparison of 28-site versus 8-site B-line score in children on dialysis.